EUCTR2009-013656-77-FR进行中（未招募）不适用
Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin.
ice University Hospital0 个研究点目标入组 0 人开始时间: 2009年8月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Both male and female patients over 8 years of age and under 64 years of age,
- •- Patients with diagnostic of lamellar ichthyosis,
- •- Patients with roughness and desquamation skin scores with moderate or severe intensity (equal or over 2 on each side of the body),
- •- Patients and/or parents /representatives of the parental authority able to understand and follow the proceedings of the study,
- •- Patients and/or parents /representatives of the parental authority willing to sign the proper consent forms,
- •- Patients covered by Social Security .
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Patients under 8 years of age,
- •- Pregnant or breastfeeding women (a qualitative urine pregnancy test will be given to all women of child-bearing age),
- •- Patients with a transaminase rate over twice the normal,
- •- Patients with congenital ichthyosis other than lamellar ichthyosis,
- •- Patients with an erythrodermic constituent,
- •- Patients with light roughness and desquamation skin scores (under 2 on one side of the body at least ),
- •- Patients with secondary infection caused by a lesion
- •- Patients with an allergy in one of the component of the trial product
- •- Patients treated with specific topics (vitamin A and D analogous for example),
- •- Patients treated with keratolytic (urea for example) in the 7 day before the beginning of the clinical trial,
- •- Patients and/or parents /representatives of the parental authority incapable of understanding (foreign language, intellectual deficiencies, motor cortex deficiencies...) and/or following the proceedings,
- •- Withdrawal of patient consent
- •- Persons already participating in another clinical trial or in the 3 monthes before the beginning of the trial.
- •- Drinkers of tea during the study
研究者
相似试验
已完成
3 期
Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine CutaneousLamellar IchthyosisNCT01222000Centre Hospitalier Universitaire de Nice6
招募中
2 期
Treatment of congenital vascular malformations using Sirolimus: improving quality of LifeNL-OMON45838Radboud Universitair Medisch Centrum75
进行中（未招募）
1 期
Treatment of congenital vascular malformations with Sirolimuscongenital vascular malformation : Vascular malformationscan involve lymphatic vessels, capillaries, veins and arteries or even combinations. These vascularmalformations are present at birth and grow with the child.MedDRA version: 20.0Level: HLTClassification code 10047091Term: Vascular malformations and acquired anomaliesSystem Organ Class: 100000005125MedDRA version: 20.0Level: LLTClassification code 10047090Term: Vascular malformation peripheralSystem Organ Class: 100000158692MedDRA version: 20.0Level: PTClassification code 10070181Term: Gastrointestinal vascular malformationSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.0Level: PTClassification code 10074979Term: Vascular malformationSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-002157-38-NLRadboud University Medical Center75
招募中
不适用
Prospective study on the treatment of congenital vaginal agenesis or vaginal hypoplasia - genital reconstruction, gynecological and urological aspects, psychosexual and social aspects and quality of lifehermaphroditismDisorders of sex developmentintersex100386081001061210029903NL-OMON36303Erasmus MC, Universitair Medisch Centrum Rotterdam545
尚未招募
不适用
International, multi-centre study on comparing management and outcomes of children born with congenital diseases between Low-Â, Middle-Â and Highâ??Income Countries.CTRI/2018/09/015833aomi Wright